Abstract

Aims: Oncotype Dx is a multi-gene test used to help define the prognosis in ER+ve node -ve breast cancer. This audit examines whether there is any further patient or pathological data that might refine the population that should get the oncotype funded.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call